Army Hospital (Research & Referral) has created history by successfully performing India’s first-ever Left Ventricular Assist Device (LVAD) implantation using the HeartMate 3 device in a ...

In a first, an Australian man has become the first in the world to live with a durable total artificial heart implant -- made ...

Cadrenal Therapeutics has entered a partnership with Abbott for the tecarfarin anticoagulation and haemocompatibility with ...

First-degree ventricular (heart) block affects the electrical signal that makes the heart beat. It causes a delay in a portion of the heart beat and may lead to a slow heart beat. Healthcare ...

One person dies every 33 seconds from heart disease, making it the leading cause of death in the United States. But for one man who had the odds stacked against ...

Abstract and Introduction Education for Treatment of LVAD Recipients Emerging Issues Surrounding LVAD Recipients Conclusion References The driveline exits the abdomen and attaches to the system ...

Ventricular assist devices are mechanical pumps ... This classifies VADs in levels or generations ( Table 2). The first generation of devices includes pulsatile volume displacement pumps (Figure ...

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized ...

Cadrenal Therapeutics (CVKD) announced the signing of a Collaboration Agreement with Abbott (ABT) ( ABT) to support Cadrenal’s pivotal ...

we have a unique opportunity to evaluate tecarfarin in combination with the HeartMate 3™ LVAD, advancing our commitment to bringing forward the first innovation in vitamin K-targeted ...